FI52714C - Process for the preparation of amino alcohols and their salts, which compounds have beta-adrenergic receptors blocking peripheral, vaso-dilatory, hypotensive, antiarrhythmic and / or the oxygen-regulating activity of the heart muscle. - Google Patents

Process for the preparation of amino alcohols and their salts, which compounds have beta-adrenergic receptors blocking peripheral, vaso-dilatory, hypotensive, antiarrhythmic and / or the oxygen-regulating activity of the heart muscle.

Info

Publication number
FI52714C
FI52714C FI702661A FI266170A FI52714C FI 52714 C FI52714 C FI 52714C FI 702661 A FI702661 A FI 702661A FI 266170 A FI266170 A FI 266170A FI 52714 C FI52714 C FI 52714C
Authority
FI
Finland
Prior art keywords
vaso
dilatory
antiarrhythmic
hypotensive
beta
Prior art date
Application number
FI702661A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI52714B (en
Inventor
Nguyen Phuc Buu-Hoi
Georges Lambelin
Joseph Roba
Guy Jacques
Claude Gillet
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of FI52714B publication Critical patent/FI52714B/fi
Application granted granted Critical
Publication of FI52714C publication Critical patent/FI52714C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/34Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI702661A 1969-10-01 1970-09-30 Process for the preparation of amino alcohols and their salts, which compounds have beta-adrenergic receptors blocking peripheral, vaso-dilatory, hypotensive, antiarrhythmic and / or the oxygen-regulating activity of the heart muscle. FI52714C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE79767 1969-10-01
BE93537 1970-09-03

Publications (2)

Publication Number Publication Date
FI52714B FI52714B (en) 1977-08-01
FI52714C true FI52714C (en) 1977-11-10

Family

ID=25647478

Family Applications (1)

Application Number Title Priority Date Filing Date
FI702661A FI52714C (en) 1969-10-01 1970-09-30 Process for the preparation of amino alcohols and their salts, which compounds have beta-adrenergic receptors blocking peripheral, vaso-dilatory, hypotensive, antiarrhythmic and / or the oxygen-regulating activity of the heart muscle.

Country Status (17)

Country Link
JP (1) JPS541693B1 (en)
AR (1) AR194457A1 (en)
AT (1) AT323135B (en)
CA (1) CA953723A (en)
CH (1) CH542177A (en)
CS (1) CS191158B2 (en)
DK (1) DK147853C (en)
FI (1) FI52714C (en)
FR (1) FR2070102A1 (en)
HU (1) HU167354B (en)
IE (1) IE34545B1 (en)
NL (1) NL156688B (en)
NO (1) NO132865C (en)
OA (1) OA03659A (en)
SE (1) SE384855B (en)
SU (1) SU578860A3 (en)
YU (1) YU35580B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386029A (en) * 1972-03-20 1975-03-05 Smithkline Corp Alpha-benzylamino-4-benzyloxy-3-alkylsulphonylmethyl phenones
DE2862340D1 (en) * 1978-02-01 1983-11-24 Wellcome Found Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
GB2067187B (en) * 1979-12-07 1983-11-30 Cosmos Enterprise Process for the preparation of 1-(4-hydroxyphenyl)-2-(4-benzylpiperidino)-1-propanol and acid addition salts thereof
FR2503705A1 (en) * 1981-04-14 1982-10-15 Synthelabo PHENETHANOLAMINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2508445A1 (en) * 1981-06-29 1982-12-31 Sori Soc Rech Ind NOVEL BENZOYL-PHENYL-PIPERIDINE DERIVATIVES, PROCESS FOR PREPARING THEM AND THEIR USE, IN PARTICULAR THERAPEUTICS
FR2534580A1 (en) * 1982-10-13 1984-04-20 Synthelabo PHENYL-1 PIPERIDINO-2 PROPANOL DERIVATIVES, THEIR PREPARATION, AND MEDICINES THAT CONTAIN THEM
FR2537132B1 (en) * 1982-12-06 1987-01-09 Lafon Labor NOVEL SULFUR DERIVATIVES OF 2-AMINO-1-PHENYL-1-ETHANOL, USE IN THERAPEUTICS AND METHOD OF PREPARATION
US5101065A (en) * 1991-02-04 1992-03-31 Imperial Chemical Industries Plc Acetophenone intermediates
FR2741067B1 (en) * 1995-11-10 1997-12-26 Rhone Poulenc Chimie PROCESS FOR ACYLATION OF AN AROMATIC THIOETHER
FR2757160B1 (en) * 1996-12-13 1999-03-12 Sanofi Sa 1-PHENYLALKYL-1,2,3,6-TETRAHYDROPYRIDINES
GB201714736D0 (en) * 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) * 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1503517A (en) * 1965-04-22 1967-12-01 Bayer Ag Manufacturing process of d - (-) - n-alkyl-1-phenyl-2-aminoethanols

Also Published As

Publication number Publication date
AT323135B (en) 1975-06-25
NO132865B (en) 1975-10-13
DK147853B (en) 1984-12-24
YU35580B (en) 1981-04-30
SE384855B (en) 1976-05-24
SU578860A3 (en) 1977-10-30
CS191158B2 (en) 1979-06-29
DK147853C (en) 1986-05-20
NL7014444A (en) 1971-04-05
AR194457A1 (en) 1973-07-23
IE34545B1 (en) 1975-06-11
FR2070102B1 (en) 1974-08-23
FI52714B (en) 1977-08-01
NO132865C (en) 1976-01-21
YU238570A (en) 1980-09-25
HU167354B (en) 1975-09-27
JPS541693B1 (en) 1979-01-27
NL156688B (en) 1978-05-16
CA953723A (en) 1974-08-27
IE34545L (en) 1971-04-01
OA03659A (en) 1971-12-24
FR2070102A1 (en) 1971-09-10
CH542177A (en) 1973-09-30

Similar Documents

Publication Publication Date Title
SE392901B (en) PROCEDURE FOR THE PREPARATION OF CERTAIN STATEMENTS 1,2,4 TRIAZOLE DERIVATIVES WHICH HAVE DEPRESSIVE ACTIVITY ON THE CENTRAL NERVOUS SYSTEM
AR193590A1 (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED 2,2'-METHYLENDIPHENOLS
FI52714C (en) Process for the preparation of amino alcohols and their salts, which compounds have beta-adrenergic receptors blocking peripheral, vaso-dilatory, hypotensive, antiarrhythmic and / or the oxygen-regulating activity of the heart muscle.
IT1017012B (en) PROCEDURE FOR THE PREPARATION OF ETHYLENE GLYCOL
IT1043829B (en) PROCEDURE FOR THE PREPARATION OF 6.7 BENZOHORFANI
TR17939A (en) IMIDAZOLIL-O, N-ACETALS AND THEIR SALTS, PROCEDURES FOR THE PREPARATION OF THESE AND THEIR USE AS FUNGICIDES
TR18457A (en) 1- PROPIL-IMIDAZOLIL TUEREVLERI AND THEIR SALTS, THE METHODS FOR THE PREPARATION OF THESE AND THEIR USE AS FUNGICIDES
IT1046112B (en) TETRAIDRO 1.3.5 TRIAZIN 2.6 DIONI PROCEDURE FOR THEIR PREPARATION AND USE AS HERBICIDES
IT971363B (en) PROCEDURE FOR THE PREPARATION OF ETHYLENE GLYCOL
IT1012110B (en) PROCEDURE FOR THE POLYMERIZATION OF ALLYL AMINE
DK115768B (en) Process for the preparation of cardiac active 3β- (2'3'-alkylidene dioxy) -α-L-rhamnoside-5β 14β-dihydroxy-19-oxo-bufa-20,22-dienolides.
TR18438A (en) 1-ETHYL-TRIAZOLES, THE PROCEDURE FOR THE PREPARATION OF THESE AND THEIR USE AS FUNGICIDES
AT321626B (en) Self-propelled corn harvester, especially for unripe corn
NL177894C (en) HEART STIMULATOR.
IT1017140B (en) PROESSO FOR THE PREPARATION OF O. BENZILTOLUENI
IT1020699B (en) PROCEDURE FOR THE RACEMIZATION OF OPTICALLY ACTIVE AMINES
IT968966B (en) PROCESS FOR THE PREPARATION OF GRANULES WITH BIOCIDAL ACTIVITY
SE421613B (en) N- (2-AMINO-3,5-DIBROMBENZYLLIDE) -TRANS-4-AMINOCYCLOHEXANOL FOR USE AS INTERMEDIATE PRODUCT FOR THE PREPARATION OF THERAPEUTIC VERDEFUL N- (2-AMINO-3,5-DIBROMBENYL-4-FORMANOL-4-DANOBLANE-TRANE-4-DANOBLANE-TRANE-4-DANOBLANE-4 ...
IT1047893B (en) PROCEDURE FOR THE PREPARATION OF AROMATIC DIAMONDS
IT966300B (en) PROCEDURE FOR THE PRODUCTION OF DIANTHRACHINONYLS
FI52096C (en) Process for the preparation of analgesically active 2,3-dihydrotiazolo (3.2.a) pyrimidin-5-ones
DK122659B (en) Analogous process for the preparation of N-substituted 2-phenoxy-2-phenylacetamides or acid addition salts thereof, which are suitable for restoring normal heart rhythm.
SE396216B (en) PROCEDURE FOR THE PREPARATION OF N- (2-AMINO-3,5-DIBROMBENZYL) -N-METHYLYCLOHEXYLAMINE
NO141181C (en) HEART BEAT MONITOR.
DK124679B (en) Analogous process for the preparation of cardiac active 4,5-epoxy-14β-hydroxybufa-20,22-dienolides.